GlobeStar Therapeutics Corp
OTC:GSTC
Income Statement
Earnings Waterfall
GlobeStar Therapeutics Corp
Income Statement
GlobeStar Therapeutics Corp
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
(0)
N/A
|
(0)
-6%
|
(0)
N/A
|
(0)
+94%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(0)
|
(1)
|
(5)
|
(9)
|
(9)
|
(9)
|
(5)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
|
| Selling, General & Administrative |
(0)
|
(1)
|
(5)
|
(9)
|
(9)
|
(9)
|
(5)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
|
| Operating Income |
(0)
N/A
|
(1)
-145%
|
(5)
-625%
|
(9)
-77%
|
(9)
-1%
|
(9)
-2%
|
(5)
+46%
|
(1)
+75%
|
(1)
+1%
|
(1)
+41%
|
(2)
-156%
|
(2)
+1%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(1)
-154%
|
(6)
-345%
|
(10)
-72%
|
(10)
-2%
|
(10)
+2%
|
(5)
+44%
|
(1)
+73%
|
(1)
+11%
|
(1)
+41%
|
(2)
-144%
|
(2)
-2%
|
|
| Net Income | |||||||||||||
| Income from Continuing Operations |
(1)
|
(1)
|
(6)
|
(10)
|
(10)
|
(10)
|
(5)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
|
| Net Income (Common) |
(1)
N/A
|
(1)
-154%
|
(6)
-345%
|
(10)
-72%
|
(10)
-2%
|
(10)
+2%
|
(5)
+44%
|
(1)
+73%
|
(1)
+11%
|
(1)
+41%
|
(2)
-144%
|
(2)
-2%
|
|
| EPS (Diluted) |
0
N/A
|
0
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|